Classic specific immunotherapy and new perspectives in specific immunotherapy for food allergy

被引:21
作者
Burks, W
Bannon, G
Lehrer, SB
机构
[1] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Res Inst, Dept Pediat Allergy & Immunol, Little Rock, AR 72202 USA
[2] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72202 USA
[3] Tulane Univ, Sch Med, Dept Med, Sect Clin Immunol Allergy & Rheumatol, Tulane, AR USA
关键词
anaphylaxis; food allergy; DNA immunization; avoidance of allergenic foods; immunotherapy;
D O I
10.1034/j.1398-9995.2001.00935.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Food allergy is a major cause of life-threatening hypersensitivity reactions. Food-induced anaphylaxis is the most common reason for someone to present to the emergency department for an anaphylactic reaction. The avoidance of the allergenic food is the only method of preventing further reactions that is currently available for sensitized patients. Strict avoidance of specific foods is the accepted treatment of food-induced allergic reactions but is often an unrealistic therapeutic option for food-induced hypersensitivity reactions for the many reasons previously described. Desirable therapeutic strategies for the treatment and prevention of food allergies must be safe, relatively inexpensive and easily administered. Recent advances in the understanding of the immunological mechanisms underlying allergic disease and better characterization of food allergens have greatly expanded the potential therapeutic options for future use. Several different forms of immunomodulatory therapies are currently under investigation: peptide immunotherapy, mutated protein immunotherapy, allergen DNA immunization, vaccination with immunostimulatory DNA sequences and anti-immunoglobulin E (Anti-IgE) therapy.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 21 条
[1]  
Asero R, 1998, CLIN EXP ALLERGY, V28, P1368, DOI 10.1046/j.1365-2222.1998.00399.x
[2]   Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy [J].
Asero, R .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 84 (04) :460-462
[3]  
Bohle B, 1999, EUR J IMMUNOL, V29, P2344, DOI 10.1002/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO
[4]  
2-R
[5]   PERIPHERAL T-CELL TOLERANCE INDUCED IN NAIVE AND PRIMED MICE BY SUBCUTANEOUS INJECTION OF PEPTIDES FROM THE MAJOR CAT ALLERGEN FEL-D-I [J].
BRINER, TJ ;
KUO, MC ;
KEATING, KM ;
ROGERS, BL ;
GREENSTEIN, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7608-7612
[6]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[7]  
Freeman J, 1930, LANCET, V1, P744
[8]   Pepsin-digested peanut contains T-cell epitopes but no IgE epitopes [J].
Hong, SJ ;
Michael, JG ;
Fehringer, A ;
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (02) :473-477
[9]  
HUS CH, 1996, NAT MED, V2, P540
[10]   A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses [J].
Li, XM ;
Serebrisky, D ;
Lee, SY ;
Huang, CK ;
Bardina, L ;
Schofield, BH ;
Stanley, JS ;
Burks, AW ;
Bannon, GA ;
Sampson, HA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (01) :150-158